<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of <z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">duodenogastric reflux</z:e> in the pathogenesis of <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> is not clear </plain></SENT>
<SENT sid="1" pm="."><plain>Using hepatobiliary scanning techniques, we found evidence of <z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">duodenogastric reflux</z:e> in six of 13 patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This compares with only two positive studies in 19 control subjects </plain></SENT>
<SENT sid="3" pm="."><plain>This difference is statistically significant (P = 0.038, two-tailed Fisher's exact test) </plain></SENT>
<SENT sid="4" pm="."><plain>Three of nine patients who had <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> without <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> had evidence of <z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">duodenogastric reflux</z:e>, a frequency not significantly different from either of the other groups </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0002020'>Gastroesophageal reflux</z:hpo> of bile and pancreatic enzymes, in addition to gastric acid may contribute to the greater esophageal damage often seen in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The presence of <z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">duodenogastric reflux</z:e> in these patients may have important pathophysiologic and therapeutic implications </plain></SENT>
</text></document>